The antitumor properties of atractylenolides: Molecular mechanisms and signaling pathways
Open Access
- 1 November 2022
- journal article
- research article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 155, 113699
- https://doi.org/10.1016/j.biopha.2022.113699
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Anti-Tumor Effects of Atractylenolide I Isolated from Atractylodes macrocephala in Human Lung Carcinoma Cell LinesMolecules, 2013
- Ethanol Extract of Atractylodes macrocephala Protects Bone Loss by Inhibiting Osteoclast DifferentiationMolecules, 2013
- Tumor glycolysis as a target for cancer therapy: progress and prospectsMolecular Cancer, 2013
- IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis DevelopmentCancer Discovery, 2012
- Anti-Oxidative Abilities of Essential Oils fromAtractylodes ovataRhizomeEvidence-Based Complementary and Alternative Medicine, 2011
- Antibacterial Activity of Phytochemicals Isolated from Atractylodes japonica against Methicillin-Resistant Staphylococcus aureusMolecules, 2010
- Paradoxical Roles of IL-4 in Tumor ImmunityCellular & Molecular Immunology, 2009
- Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial CellsClinical Cancer Research, 2009
- GSK3β inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytesCellular Signalling, 2008
- Common markers of proliferationNature Reviews Cancer, 2006